Moderna | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$20,000,000
Funder
Coalition for Epidemic Preparedness Innovations (CEPI)
Principal Investigator
Pending
Research Location
United States of America
Lead Research Institution
Moderna
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Phase 1 clinical trial
Special Interest Tags
N/A
Study Subject
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

mRNA1273 encodes for a pre-fusion stabilized Spike protein of 2019-nCoV Phase I safety and immunogenicity

Publicationslinked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

Patient experience of the process to diagnosis of chronic limb-threatening ischaemia: A qualitative study.

Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial.

Beyond Crop-Raiding: Unravelling the Broader Impacts of Human-Wildlife Conflict on Rural Communities.

Treatment of IDH-mutant glioma in the INDIGO era.

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy.

Extended high-frequency hearing loss among Afro-Colombian adolescents from a rural area in Colombia: a cross-sectional study.

Direct observation correlates NFκB cRel in B cells with activating and terminating their proliferative program.

Factors associated with the quality of corneas retrieved for transplantation by Eye Banks: a scoping review protocol.